By Professor Naresh Kumar

Conference Proceedings (Editor of)

Deodhar M; Black DS; Heaton A; Kumar N, (eds.), 2007, '21st International Congress for Heterocyclic Chemistry', University of New South Wales, presented at 21st International Congress for Heterocyclic Chemistry, University of New South Wales, 15 July 2007 - 20 July 2007

Alamgir M; Black DS; Kumar N, (eds.), 2007, '21st International Congress for Heterocyclic Chemistry', University of New South Wales, presented at 21st International Congress for Heterocyclic Chemistry, University of New South Wales, 15 July 2007 - 20 July 2007

Somphol K; Black DS; Kumar N, (eds.), 2007, '21st International Congress for Heterocyclic Chemistry', University of New South Wales, presented at 21st International Congress for Heterocyclic Chemistry, University of New South Wales, 15 July 2007 - 20 July 2007

Leu C; Black DS; Kumar N, (eds.), 2007, '21st International Congress for Heterocyclic Chemistry', University of New South Wales, presented at 21st International Congress for Heterocyclic Chemistry, University of New South Wales, 15 July 2007 - 20 July 2007

Manefield MJ; De Nys R; Kumar N; Read RW; Givskov M; Steinberg PD; Kjelleberg S, (eds.), 1998, 'Natural Products Chemistry Group Annual One-Day Symposium', University of Sydney, presented at Natural Products Chemistry Group Annual One-Day Symposium, University of Sydney, 02 October 1998

Lao W; Manny AJ; Kumar N; Read RW, (eds.), 1998, 'Natural Products Chemistry Group Annual One-Day Symposium', University of Sydney, presented at Natural Products Chemistry Group Annual One-Day Symposium, University of Sydney, 02 October 1998

Conference Abstracts

Netto KG; Chiang S; Kokkinos J; Haghighi KS; Raina A; Pitiyarachchi O; Youkhana J; Truong Q; Wenholz D; Li X; Laczka O; Kumar N; Wilkinson J; Goldstein D; Sharbeen G; Phillips PA, 2024, 'Abstract B062: CRO67 has therapeutic potential against pancreatic tumor cells and cancer associated fibroblasts', in Cancer Research, American Association for Cancer Research (AACR), Vol. 84, pp. b062 - b062, http://dx.doi.org/10.1158/1538-7445.panca2023-b062

Sara M; Kuppusamy R; Afzal M; Khan M; Yasir M; Kalaiselvan P; Hui A; Kumar N; Willcox M, 2021, 'Synergistic activity of a peptide mimic with quinolones and cephalosporins against Staphylococcus aureus', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, ELECTR NETWORK, Vol. 62, presented at Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), ELECTR NETWORK, 01 May 2021 - 07 May 2021

Yee EMH; Brandl MB; Pasquier E; Cirillo G; Kimpton K; Kavallaris M; Kumar N; Vittorio O, 2017, 'Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells', in Scientific Reports, Springer Nature, England, Vol. 7, pp. 7638, England, http://dx.doi.org/10.1038/s41598-017-07452-w

Taunk A; Iskander G; HO KKK; Willcox MDP; Kumar N, 2016, 'Immobilization of quorum sensing inhibitors to develop antibacterial biomaterials', in Frontiers in Bioengineering and Biotechnology, Montreal, Canada, presented at 10th World Biomaterials Congress, Montreal, Canada, 17 May 2016 - 22 May 2016, http://dx.doi.org/10.3389/conf.FBIOE.2016.01.02320

Theses / Dissertations

Alamgir M; Kumar N, 2007, Synthesis and reactivity of some activated heterocyclic compounds

Maharaj F; Kumar N; Bishop R, 2007, Synthetic strategies for the development of functionalised calix[4]arenes for the study of their host-guest chemistry

Lao W; Read RW; Kumar N, 2002, Synthetic Studies Towards the Fimbrolides and AHL autoinducers

Patents

Kumar N; Willcox M; Nizalapur S; Black D; Yu TT; Kuppusamy R, 2021, Antimicrobial compounds, Patent No. United States 2021 pat no. 10988444; New Zealand - 754200;

Kumar N, 2007, Lactams, processes for preparing them, pharmaceutical compositions containing them, and their use as antibacterial agents, Patent No.

Kumar N, 2006, Production of Isoflavonoid dimers as therapeutic agents derivatives, Patent No.

Kumar N, 2005, Association of antimicrobial furanone/lactam compounds with surfaces and polymers, Patent No.

Kumar N, 2005, Preparation of halomethylene alkanones as regulators of bacterial signalling pathways, Patent No.

Preprints

Ng SW; Gadde S; Chung N-Y; Wang Q; Doughty L; Nero TL; Jayatilleke N; Seneviratne J; Carter DR; Mateos MK; Tsoli M; Ziegler DS; Endersby R; Kumar N; Chesler L; Liu T; Parker MW; Cheung BB; Marshall GM, 2026, Therapeutic targeting of MYC- and MYCN-driven medulloblastoma with a novel MYC degrader molecule, http://dx.doi.org/10.64898/2026.07.09.737604

Gautam S; Mawari G; Daga MK; Kumar N, 2021, A case report on uneventful anticoagulation and persistence of type1 respiratory failure post severe COVID-19 infection in a patient of Osler-Weber-Rendu Syndrome., http://dx.doi.org/10.21203/rs.3.rs-941184/v1

Urmi UL; Attard S; Vijay AK; Willcox MDP; Kumar N; Islam S; Kuppusamy R, Antiviral Activity of Anthranilamide Peptidomimetics against Herpes Simplex Virus 1 and a Coronavirus, http://dx.doi.org/10.20944/preprints202308.2017.v1

Daga MK; Mawari G; Wasi S; Kumar N; Sharma U; Hussain M, Current Pattern and Clinico-Bacteriological Profile of Healthcare Associated Infections (HAI) in an ICU Setting: An Observational Study, http://dx.doi.org/10.21203/rs.3.rs-874099/v1

Grunfeld DA; Jones AM; Sun J; Le ST; Pickford R; Huang Q; Manefield M; Kumar N; Lee M; O’Carroll D, Electrochemical Degradation of a Perfluoroalkyl Substance (Pfas) Using a Simple Activated Carbon Cathode, http://dx.doi.org/10.2139/ssrn.4203122

Gantier M; Ullah T; Johansen M; Balka K; Ambrose R; Gearing L; Wenholz D; Zeng J; Miemczyk S; Nguyen D; Venkatraman R; Dennis M; Alharbi A; Ellyard J; Wong W; Kile B; Vinuesa C; Kelly G; Hansbro P; Laczka O; De Nardo D; Hansbro N; Kumar N, Pharmacological inhibition of TBK1/IKKε blunts COVID-19 immunopathology, http://dx.doi.org/10.21203/rs.3.rs-1336801/v1

Gadde S; Kleynhans A; Holien J; Bhadbhade M; Nguyen PLD; Mittra R; Carter D; Marshall G; Cheung B; Kumar N, Pyrimido[1,2-A]Benzimidazoles as Inhibitors of Oncoproteins Ubiquitin Specific Protease 5 and MYCN in the Childhood Cancer Neuroblastoma, http://dx.doi.org/10.2139/ssrn.4283384

Back to profile page